A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

Stopped Program stopped due to the benefit risk profile no longer supports further development in the intended patient population.

Conditions

• Eosinophilic Asthma
• Asthma; Eosinophilic
• Asthma

Interventions

• DRUG: Dexpramipexole Dihydrochloride
• DRUG: Placebo

Sponsor

Areteia Therapeutics